# OnCo record nct07281976 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07281976/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07281976", "NCT07281976" ;
  schema:name "A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer"@en ;
  schema:description "A phase 1/2 trial of Toripalimab in triple-negative breast cancer, run by Nanjing Leads Biolabs Co.,Ltd, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07281976/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07281976> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2026-01-27" ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/tnbc-metastatic/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/toripalimab/> ;
  onco:companies <https://onco.cc/companies/nanjing-leads-biolabs/> .